Stella Xu
CIK 1728741 · last filed 2023-06-02
Stella Xu is a corporate insider who has filed 15 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for DSGN, was dated Jun 2, 2023. Across all open-market trades the lifetime net is −$9.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $48.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$48.49M
4
15
-$9.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DSGN | Director | 4,168,605 | $10.97 | $45.73M | -$11.07M | 5 | 2023-06-02 |
| TPST | Director | 579,710 | $1.26 | $730.4K | $0 | 3 | 2021-09-20 |
| NXTC | Director | 978,570 | $2.08 | $2.03M | $1.88M | 4 | 2021-06-28 |
| ARMO BioSciences, Inc. (ARMO) Delisted | Director | 0 | — | — | $0 | 3 | 2018-06-22 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-02 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2022-03-22 | DSGN | Sell (S) | −590,880 | -$11.27M | EDGAR |
| 2021-09-20 | TPST | Grant (A) | — | $0 | EDGAR |
| 2021-07-06 | TPST | Grant (A) | — | $0 | EDGAR |
| 2021-06-29 | TPST | Grant (A) | +579,710 | $0 | EDGAR |
| 2021-06-28 | NXTC | Grant (A) | — | $0 | EDGAR |
| 2021-04-01 | DSGN | Mixed | +4,730,830 | $200.0K | EDGAR |
| 2021-03-29 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2020-06-15 | NXTC | Grant (A) | — | $0 | EDGAR |